Amina Jindani

2.5k total citations · 1 hit paper
23 papers, 1.4k citations indexed

About

Amina Jindani is a scholar working on Infectious Diseases, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Amina Jindani has authored 23 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 14 papers in Epidemiology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Amina Jindani's work include Tuberculosis Research and Epidemiology (14 papers), Pneumocystis jirovecii pneumonia detection and treatment (7 papers) and Mycobacterium research and diagnosis (7 papers). Amina Jindani is often cited by papers focused on Tuberculosis Research and Epidemiology (14 papers), Pneumocystis jirovecii pneumonia detection and treatment (7 papers) and Mycobacterium research and diagnosis (7 papers). Amina Jindani collaborates with scholars based in United Kingdom, France and South Africa. Amina Jindani's co-authors include Eric Edwards, D A Mitchison, V R Aber, D.A. Mitchison, Caroline J Doré, Andrew Nunn, D. A. Enarson, E Neville, Brittney Williams and G E Venn and has published in prestigious journals such as The Lancet, American Journal of Respiratory and Critical Care Medicine and Cancer.

In The Last Decade

Amina Jindani

23 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The early bactericidal activity of drugs in patients with pulmonary tuberculosis.

1980 369 citations Amina Jindani et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amina Jindani United Kingdom	15	970	893	437	200	170	23	1.4k
Florian von Groote-Bidlingmaier South Africa	18	919 0.9×	711 0.8×	345 0.8×	278 1.4×	44 0.3×	36	1.5k
I. А. Vаsilyevа Russia	15	1.1k 1.1×	744 0.8×	410 0.9×	378 1.9×	44 0.3×	92	1.5k
Els De Paepe Belgium	15	964 1.0×	679 0.8×	163 0.4×	147 0.7×	46 0.3×	28	1.2k
Gregory Symons South Africa	9	694 0.7×	523 0.6×	276 0.6×	164 0.8×	46 0.3×	15	882
Brian Dannemann United States	12	883 0.9×	938 1.1×	262 0.6×	267 1.3×	28 0.2×	17	1.5k
Nyasha Bakare United States	14	850 0.9×	618 0.7×	257 0.6×	288 1.4×	43 0.3×	18	1.2k
Andreas H. Diacon South Africa	14	952 1.0×	677 0.8×	346 0.8×	250 1.3×	18 0.1×	20	1.4k
Saskia Kuipers Netherlands	20	268 0.3×	311 0.3×	182 0.4×	115 0.6×	137 0.8×	42	1.1k
Christo van Niekerk South Africa	9	1.3k 1.4×	945 1.1×	387 0.9×	437 2.2×	16 0.1×	12	1.6k
Heping Xiao China	21	670 0.7×	575 0.6×	341 0.8×	148 0.7×	26 0.2×	77	1.2k

Countries citing papers authored by Amina Jindani

Since Specialization

Citations

This map shows the geographic impact of Amina Jindani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amina Jindani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amina Jindani more than expected).

Fields of papers citing papers by Amina Jindani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amina Jindani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amina Jindani. The network helps show where Amina Jindani may publish in the future.

Co-authorship network of co-authors of Amina Jindani

This figure shows the co-authorship network connecting the top 25 collaborators of Amina Jindani. A scholar is included among the top collaborators of Amina Jindani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amina Jindani. Amina Jindani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dorman, Susan E., Amina Jindani, Kelly E. Dooley, et al.. (2020). Rifapentine Population Pharmacokinetics and Dosing Recommendations for Latent Tuberculosis Infection. American Journal of Respiratory and Critical Care Medicine. 202(6). 866–877. 22 indexed citations

Zvada, Simbarashe, Paolo Denti, Mark Hatherill, et al.. (2019). A Population Pharmacokinetic Analysis Shows that Arylacetamide Deacetylase (AADAC) Gene Polymorphism and HIV Infection Affect the Exposure of Rifapentine. Antimicrobial Agents and Chemotherapy. 63(4). 20 indexed citations

Witney, Adam A., Amina Jindani, Patrick Phillips, et al.. (2017). Use of whole-genome sequencing to distinguish relapse from reinfection in a completed tuberculosis clinical trial. BMC Medicine. 15(1). 71–71. 41 indexed citations

Atwine, Daniel, Patrick Orikiriza, Ivan Mugisha Taremwa, et al.. (2017). Predictors of delayed culture conversion among Ugandan patients. BMC Infectious Diseases. 17(1). 299–299. 4 indexed citations

Jindani, Amina, Gábor Borgulya, Bhawana Shrestha, et al.. (2016). A randomised Phase II trial to evaluate the toxicity of high-dose rifampicin to treat pulmonary tuberculosis. The International Journal of Tuberculosis and Lung Disease. 20(6). 832–838. 35 indexed citations

Nunn, Andrew, et al.. (2014). Results at 30 months of a randomised trial of FDCs and separate drugs for the treatment of tuberculosis. The International Journal of Tuberculosis and Lung Disease. 18(10). 1252–1254. 8 indexed citations

Zvada, Simbarashe, Paolo Denti, Frederick A. Sirgel, et al.. (2013). Moxifloxacin Population Pharmacokinetics and Model-Based Comparison of Efficacy between Moxifloxacin and Ofloxacin in African Patients. Antimicrobial Agents and Chemotherapy. 58(1). 503–510. 35 indexed citations

Zvada, Simbarashe, Paolo Denti, Hennie Geldenhuys, et al.. (2012). Moxifloxacin Population Pharmacokinetics in Patients with Pulmonary Tuberculosis and the Effect of Intermittent High-Dose Rifapentine. Antimicrobial Agents and Chemotherapy. 56(8). 4471–4473. 29 indexed citations

Lienhardt, Christian, Leen Rigouts, Su-Jeong Kim, et al.. (2011). Efficacy and Safety of a 4-Drug Fixed-Dose Combination Regimen Compared With Separate Drugs for Treatment of Pulmonary Tuberculosis. UCL Discovery (University College London). 5 indexed citations

10.

Nunn, Andrew, et al.. (2011). Results at 30 months of a randomised trial of two 8-month regimens for the treatment of tuberculosis. The International Journal of Tuberculosis and Lung Disease. 15(6). 741–745. 18 indexed citations

11.

Jindani, Amina & George E. Griffin. (2010). Challenges to the development of new drugs and regimens for tuberculosis. Tuberculosis. 90(3). 168–170. 6 indexed citations

12.

Jindani, Amina, Andrew Nunn, & D. A. Enarson. (2004). Two 8-month regimens of chemotherapy for treatment of newly diagnosed pulmonary tuberculosis: international multicentre randomised trial. The Lancet. 364(9441). 1244–1251. 177 indexed citations

13.

Jindani, Amina, Caroline J Doré, & D.A. Mitchison. (2003). Bactericidal and Sterilizing Activities of Antituberculosis Drugs during the First 14 Days. American Journal of Respiratory and Critical Care Medicine. 167(10). 1348–1354. 242 indexed citations

14.

Harries, Anthony, J Kemp, Amina Jindani, et al.. (2001). Deaths from tuberculosis in sub-Saharan African countries with a high prevalence of HIV-1. The Lancet. 357(9267). 1519–1523. 128 indexed citations

15.

Harries, A D, N J Hargreaves, Amina Jindani, et al.. (2001). <b>Viewpoint</b><br><br>Deaths form tuberculosis in African countries with a high prevalence of HIV-1. Malawi Medical Journal. 13(4). 1 indexed citations

16.

Pellerin, Michel, Serban Mihaileanu, J.P. Couetil, et al.. (1995). Carpentier-edwards pericardial bioprosthesis in aortic position: Long-term follow-up 1980 to 1994. The Annals of Thoracic Surgery. 60(2 Suppl). S292–S296. 36 indexed citations

17.

Williams, Brittney & Amina Jindani. (1994). New trends in the postoperative management of cardiac surgical patients. A review.. PubMed. 35(2). 161–3. 3 indexed citations

18.

Jindani, Amina, et al.. (1993). Postoperative cardiac surgical care: an alternative approach. Heart. 69(1). 59–63. 35 indexed citations

19.

Jindani, Amina, E Neville, G E Venn, & Brittney Williams. (1991). Paraprosthetic leak: a complication of cardiac valve replacement.. PubMed. 32(4). 503–8. 110 indexed citations

20.

Baillet, F, M Weil, G Auclerc, et al.. (1988). Results of a conservative treatment combining induction (neoadjuvant) and consolidation chemotherapy, hormonotherapy, and external and interstitial irradiation in 98 patients with locally advanced breast cancer (IIIA-IIIB). Cancer. 61(10). 1977–1982. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact